📖
Phage-first treatment results in subpopulation-driven collateral sensitivity to beta-lactams in an extensively drug-resistant Pseudomonas aeruginosa.
Han C, Patel K, Gao H, Sanborn JT, Nguyen TD, Klem JF, Ho BM, Kenney PD, Zhao Y, Wood TD, Roach DR, Chen L, Smith NM

Phage-first treatment results in subpopulation-driven collateral sensitivity to beta-lactams in an extensively drug-resistant Pseudomonas aeruginosa.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Antimicrob Agents Chemother.

Advertisement
SPONSOR CONTENT
Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Phage-first treatment results in subpopulation-driven collateral sensitivity to beta-lactams in an extensively drug-resistant Pseudomonas aeruginosa.
Author / Organization Han C, Patel K, Gao H, Sanborn JT, Nguyen TD, Klem JF, Ho BM, Kenney PD, Zhao Y, Wood TD, Roach DR, Chen L, Smith NM
Subject & Discipline Antimicrob Agents Chemother
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-68615
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »